Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:46 PM
Ignite Modification Date:
2025-12-24 @ 10:46 PM
NCT ID:
NCT05678569
Eligibility Criteria:
Inclusion Criteria:
* Age \>=50y
* Age \<=80y
* Identified as high risk by initial model
Exclusion Criteria:
* Age \<50y
* Age \>80y
* BMI \<=18 \& \>=30
* Recorded diagnosis of osteoporosis
* Prior prescription of bone protective agents such as:
bisphosphonate (alendronic acid, risedronate, ibandronate, zoledronic acid) / denosumab / raloxifene / strontium ranelate / teriparatide / romosozumab
* History of prior DXA imaging (prior quantification of BMD)
* History of metabolic bone disease
* History of primary hyperparathyroidism
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
50 Years
Maximum Age:
80 Years
Study:
NCT05678569
Study Brief:
Protocol Section:
NCT05678569